Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.
The P/B ratio is 1358.25 as of 2026-10-06T22:40:22.158Z.
Calculation as of: 2026-10-06T22:40:22.158Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b7fd3b5d8e417d78924f6cd313032c2aac5600bd184120b35a4860f29c1b1599
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PB RATIO
1358.25
SECTOR MEDIAN · HEALTHCARE
2.39
median of 761 covered companies
CURRENT VS SECTOR MEDIAN
+56730.54%
vs the sector median at left
Market Cap
$69.61M
PB Ratio
17.88
TTM Avg
21.25
3Y Avg
131.92
5Y Avg
75.65
Market Cap
$72.32M
PB Ratio
16.79
TTM Avg
10.91
3Y Avg
49.43
5Y Avg
23.54
| NAME | MARKET CAP | PB RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tiziana Life Sciences Ltd (TLSA) | $70.63M | 1358.25 | N/A | N/A | N/A |
| Gain Therapeutics, Inc. (GANX)vs › | $71.23M | 6.31 | 10.24 | 7.44 | 5.31 |
| Champions Oncology, Inc. (CSBR)vs › | $69.61M | 17.88 | 21.25 | 131.92 | 75.65 |
| Verrica Pharmaceuticals Inc. (VRCA)vs › | $72.32M | 16.79 | 10.91 | 49.43 | 23.54 |
| Spero Therapeutics, Inc. (SPRO)vs › | $68.90M | 1.56 | 3.39 | 2.11 | 2.06 |
| MindWalk Holdings Corp. (HYFT)vs › | $72.83M | 14.78 | 7.11 | 3.22 | 2.78 |
| Fortress Biotech, Inc. (FBIO)vs › | $68.10M | 0.41 | 1.39 | 1.48 | 1.46 |
| Hyperfine, Inc. (HYPR)vs › | $73.27M | 1.99 | 3.13 | 1.86 | 1.54 |
| iBio, Inc. (IBIO)vs › | $67.52M | 0.79 | 2.38 | 1.32 | 1.05 |
| Pulmonx Corporation (LUNG)vs › | $75.18M | 1.92 | 1.39 | 2.18 | 2.79 |
P/B Ratio
1358.25
Market Price / Book Value per Share
PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)
The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
